[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK0515415T3 - Hidtil ukendt vaccine og fremgangsmåde til fremstilling deraf - Google Patents

Hidtil ukendt vaccine og fremgangsmåde til fremstilling deraf

Info

Publication number
DK0515415T3
DK0515415T3 DK91903336.5T DK91903336T DK0515415T3 DK 0515415 T3 DK0515415 T3 DK 0515415T3 DK 91903336 T DK91903336 T DK 91903336T DK 0515415 T3 DK0515415 T3 DK 0515415T3
Authority
DK
Denmark
Prior art keywords
preparation
hitherto unknown
vaccine
unknown vaccine
detoxified
Prior art date
Application number
DK91903336.5T
Other languages
English (en)
Inventor
Carine Capiau
Jean Petre
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Application granted granted Critical
Publication of DK0515415T3 publication Critical patent/DK0515415T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK91903336.5T 1990-02-12 1991-02-07 Hidtil ukendt vaccine og fremgangsmåde til fremstilling deraf DK0515415T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47909890A 1990-02-12 1990-02-12

Publications (1)

Publication Number Publication Date
DK0515415T3 true DK0515415T3 (da) 1995-11-27

Family

ID=23902647

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91903336.5T DK0515415T3 (da) 1990-02-12 1991-02-07 Hidtil ukendt vaccine og fremgangsmåde til fremstilling deraf

Country Status (17)

Country Link
EP (1) EP0515415B1 (da)
JP (1) JP3035712B2 (da)
KR (1) KR100202052B1 (da)
AT (1) ATE129159T1 (da)
AU (1) AU646019B2 (da)
CA (1) CA2075711C (da)
CY (1) CY1935A (da)
DE (1) DE69113991T2 (da)
DK (1) DK0515415T3 (da)
ES (1) ES2080941T3 (da)
GR (1) GR3018440T3 (da)
HK (1) HK1004524A1 (da)
IE (1) IE70672B1 (da)
NZ (1) NZ237069A (da)
PT (1) PT96723B (da)
WO (1) WO1991012020A1 (da)
ZA (1) ZA91947B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0835663B1 (en) 1992-05-23 2009-09-30 GlaxoSmithKline Biologicals S.A. Combined vaccines comprising Hepatitis B surface antigen and other antigens
GB9216351D0 (en) * 1992-07-31 1992-09-16 Wellcome Found Vaccine production
EP1107782B1 (en) * 1998-09-01 2009-12-23 Merrion Research III Limited Oral vaccine compositions
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
GB0313916D0 (en) 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
BR112014017898B1 (pt) 2012-02-01 2021-10-13 Glaxosmithkline Biologicals S.A. Processo de fermentação
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
CA2879939A1 (en) 2012-08-06 2014-02-13 Glaxosmithkline Biologicals S.A. Novel method
NZ630868A (en) 2013-03-08 2017-02-24 Janssen Vaccines & Prevention Bv Acellular pertussis vaccine
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
EA201690115A1 (ru) 2013-08-05 2016-07-29 Глаксосмитклайн Байолоджикалс С.А. Комбинированные иммуногенные композиции

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070454A (en) * 1973-05-04 1978-01-24 Agence Nationale De Valorisation De La Recherche (Anvar) Vaccines, the process for preparing the same and the applications thereof
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
US4888169A (en) * 1986-10-14 1989-12-19 Norden Laboratories, Inc. Bordetella Bronchiseptica vaccine
AU5027890A (en) * 1989-02-10 1990-09-05 Genesit Oy A method for producing pertussis toxin subunits

Also Published As

Publication number Publication date
HK1004524A1 (en) 1998-11-27
EP0515415A1 (en) 1992-12-02
ZA91947B (en) 1992-01-29
NZ237069A (en) 1993-07-27
KR920703099A (ko) 1992-12-17
CA2075711A1 (en) 1991-08-13
KR100202052B1 (ko) 1999-06-15
JP3035712B2 (ja) 2000-04-24
DE69113991T2 (de) 1996-03-21
ES2080941T3 (es) 1996-02-16
AU7211091A (en) 1991-09-03
JPH05503936A (ja) 1993-06-24
WO1991012020A1 (en) 1991-08-22
PT96723B (pt) 1998-07-31
IE70672B1 (en) 1996-12-11
EP0515415B1 (en) 1995-10-18
GR3018440T3 (en) 1996-03-31
DE69113991D1 (de) 1995-11-23
CY1935A (en) 1991-02-07
AU646019B2 (en) 1994-02-03
IE910424A1 (en) 1991-08-14
ATE129159T1 (de) 1995-11-15
PT96723A (pt) 1991-10-31
CA2075711C (en) 2000-11-07

Similar Documents

Publication Publication Date Title
DK0515415T3 (da) Hidtil ukendt vaccine og fremgangsmåde til fremstilling deraf
NO1997010I1 (no) Bordetella pertussis P69 antigen
DE69022106D1 (de) Pertussistoxin-Mutanten, dieselbe produzierende Bordetella-Stämme und ihre Verwendung als Vakzin gegen Pertussis.
DK694687A (da) Hidtil ukendte oligosaccharider, immunogener og vacciner og fremgangsmaader til fremstilling af disseoligosaccharider, immunogener og vacciner
DE3785157D1 (de) Verfahren zur herstellung von toxoid.
DK365287A (da) Fremgangsmaade til dyrkning af bordetella pertussis, pertussis toxoid, pertussis vacciner og fremgangsmaade til fremstilling af pertussis vacciner
DK154140C (da) Fremgangsmaade til fremstilling af 2,3-dihydro-2,2-dimethyl-7-hydroxybenzofuran
FI861966A (fi) Renad och tre gaonger klonad hepatit-a-virus.
DE68917709D1 (de) Verfahren zur Herstellung eines Pertussis-Toxin-Toxoides.
DK328581A (da) Fremgangsmaade til fremstilling af 6-aminopenicillansyre-1,1-dioxid
FR2601250B1 (fr) Procede de preparation de fractions antigeniques exocellulaires de bordetella pertussis et vaccin contre la coqueluche contenant de telles fractions.
IT9019286A0 (it) Mutanti della tossina della pertosse, ceppi di bordetella capaci di produrre detti mutanti e loro impiego per lo sviluppo di vaccini antipertosse
BG50962A1 (en) Method of producing live lyophilied vaccine against infection caused by salmonella typhimurium